Head to Head Survey: biote (NASDAQ:BTMD) versus Field Trip Health (OTCMKTS:FTRPF)

Field Trip Health (OTCMKTS:FTRPFGet Free Report) and biote (NASDAQ:BTMDGet Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Field Trip Health and biote, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Field Trip Health 0 0 0 0 0.00
biote 1 1 1 1 2.50

biote has a consensus price target of $2.50, suggesting a potential upside of 53.85%. Given biote’s stronger consensus rating and higher possible upside, analysts clearly believe biote is more favorable than Field Trip Health.

Insider and Institutional Ownership

21.7% of biote shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Field Trip Health and biote’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Field Trip Health N/A N/A N/A
biote 3.19% -22.33% 12.10%

Earnings and Valuation

This table compares Field Trip Health and biote”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Field Trip Health N/A N/A N/A N/A N/A
biote $183.53 million 0.32 $27.05 million $0.11 14.77

biote has higher revenue and earnings than Field Trip Health.

Summary

biote beats Field Trip Health on 9 of the 10 factors compared between the two stocks.

About Field Trip Health

(Get Free Report)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics. The company also operates Field Trip Health clinics for psychedelic therapies in North America. Its Technology division engages in building digital and technological tools to support psychedelic experiences and consciousness expansion. Field Trip Health Ltd. is headquartered in Toronto, Canada.

About biote

(Get Free Report)

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.